Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation

Neurology

Volumn 67, Issue 9, 2006, Pages 1715-1717

  Galimberti, C A ^a   Diegoli, M ^b   Sartori, I ^a   Uggetti, C ^a   Brega, A ^c,d   Tartara, A ^a   Arbustini, E ^b  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; MITOCHONDRIAL DNA; VALPROIC ACID;

ANAMNESIS; ARTICLE; BRAIN ATROPHY; BRAIN PSEUDOATROPHY; CASE REPORT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; EVOKED RESPONSE; FOCAL EPILEPSY; GENE MUTATION; GENERALIZED EPILEPSY; HUMAN; IRRITABILITY; LABORATORY TEST; LEARNING DISORDER; MALE; MENTAL DETERIORATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT WITHDRAWAL; UNCONSCIOUSNESS; WECHSLER INTELLIGENCE SCALE;

ADULT; AGED; ANTICONVULSANTS; ATROPHY; BRAIN; CHILD; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; POLYMORPHISM, GENETIC; VALPROIC ACID;

EID: 33750990215     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000242882.58086.9a     Document Type: Article

References (7)

1. McLachlan RS. Pseudoatrophy of the brain with valproic acid monotherapy. Can J Neurol Sci 1987;14:294-296.
2. Papazian O, Canizales E, Alfonso I, Archila R, Duchowny M, Aicardi J. Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 1995;38:687-691.
3. Guerrini R, Belmonte A, Canapicchi R, Casalini C, Perucca E. Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment. Epilepsia 1998;39:27-32.
4. Straussberg R, Kivity S, Weitz R, Harel L, Gadoth N. Reversible cortical atrophy and cognitive decline induced by valproic acid. Eur J Paediatr Neurol 1998;2:213-218.
5. Lam CW, Lau CH, Williams JC, Chan YW, Wong LJ. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 1997;156:562-564.
6. Povalko N, Zakharova E, Rudenskaia G, et al. A new sequence variant in mitochondrial DNA associated with high penetrance of Russian Leber hereditary optic neuropathy. Mitochondrion 2005;5:194-199.
7. MITOMAP: a human mitochondrial genome database. http://www.mitomap.org, 2006.